Navigation Links
IMPAKT Breast Cancer Conference press program
Date:5/6/2010

Press releases (embargo: 6 May, 16:45 CEST)

J. Hicks, USA
Genome breakthrough allows scientists to identify and profile tumor cells from very small samples
Researchers have developed a powerful new technique for analyzing the genome of single tumor cells. The breakthrough allows them to study in fine detail the biology of how tumors develop.

S. Loi, BE
Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
An international team of researchers has discovered molecular evidence that may explain why some women with HER2 over-expressing breast cancer do not respond to drugs designed to target this important molecule.

B. Haine-Kains, USA
Simple gene test identifies clinically important sub-types of breast cancer
A simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types.

A. Giordano, USA
Survival in metastatic breast cancer directly linked to circulating tumor cells
A new study of metastatic breast cancer shows that the number of circulating tumor cells patients have in their blood directly correlates with the length of their survival.

The full conference program is available at http://www.esmo.org/events/breast-2010-impakt/program.html

Press conference

Thursday, 06/05 at 12:00-13:00 (CEST)

Hosts:
Dr Martine Piccart, Head of Chemotherapy Unit, Jules Bordet Institute in Brussels, IMPAKT Co-Founder
Dr Angelo Di Leo, Head of Medical Oncology Unit, Department of Oncology, Hospital of Prato, Italy, IMPAKT2010 Co-Chair
Dr Christos Sotiriou, Head of Functional Genomics & Translational Research Unit, Jules Bordet Institute in Brussels, IMPAKT2010 Co-Chair

Topics:

  • The impact of methodology in biomarkers research and validation
  • Translational research impact on the next decade
  • Impact of neo-adjuvant trial results in the future treatment practice


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. Estrogen receptor status of HER2+ breast cancer correlates with response to anti-HER therapies
2. Simple gene test identifies clinically important subtypes of breast cancer
3. Survival in metastatic breast cancer directly linked to circulating tumor cells
4. Breast cancer metastasis increases after estrogen and progestin hormone therapies, MU study finds
5. Broccoli May Help Battle Breast Cancer
6. Edgy, Sassy And Informative: New Website for Breast Cancer Survivors To Get Real About Their 'New Normal'
7. Whole body MRI is highly accurate in the early detection of breast cancer metastases
8. PMH cancer researchers link ovarian hormone to breast stem cells growth
9. Hutchinson Center receives $10.24 million from NIH for Latina breast cancer research
10. Aggressive Action Urged When Evaluating Breast Lesions
11. Indeterminate breast lesions found in high-risk patients should be evaluated aggressively to exclude malignancy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... 12, 2017 , ... CitiDent and San Francisco dentists, Dr. ... Oventus O2Vent technology. As many as 18 million Americans are estimated to suffer ... Oral appliances can offer significant relief to about 75 percent of people with ...
(Date:10/12/2017)... , ... October 12, 2017 , ... IsoComforter, Inc. ( ... announced today the introduction of an innovative new design of the shoulder pad. ... you get maximum comfort while controlling your pain while using cold therapy. By utilizing ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s ... the 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. ... Center for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, ...
(Date:10/12/2017)... ... ... Health Literacy Innovations (HLI), creator of the Health Literacy ... Patient Education Network (CPEN), an independent professional organization that shares best practices in ... , As CPEN’s strategic partner, HLI will help support CPEN members by sharing ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital ... its MyDario product is expected to appear on The Dr. Oz Show ... Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked off ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: